Introduction Sunbed use has been significantly associated with increased risk of melanoma and non-melanoma skin
Introduction
The use of artificial tanning lamps for cosmetic purposes is extremely common in developed areas of the world including Europe. 1 This raises concern among health providers and legislators, as sunbed use has been associated with an increased risk of melanoma and non-melanoma skin cancer (NMSC) by several studies, summarized in meta-analyses. [2] [3] [4] [5] [6] [7] [8] Indeed,
the International Agency for Research on Cancer (IARC) currently regards the whole spectrum of ultraviolet (UV) radiation as well as UV-emitting tanning devices as first-group carcinogens alongside tobacco smoking and asbestos. 9, 10 Associations between indoor tanning exposure and melanoma's risk factors such as high nevus count, atypical nevi and lentigines have also been suggested, though not extensively studied up to date. [11] [12] [13] [14] [15] [16] [17] [18] [19] Euromelanoma is a skin cancer prevention campaign that is conducted all over Europe since almost two decades. [20] [21] [22] Its main goal is to promote awareness of skin cancer among the general public. Euromelanoma aims therefore to inform and educate the population as to how to prevent skin cancer by avoiding modifiable risk factors, and to recognize suspicious skin lesions by skin self-examination. Moreover, Euromelanoma offers once-a-year free screenings to the general public, during which screenees and physicians are requested to complete a questionnaire enquiring about participants' socio-demographics, phenotype, risk factors (including sunbed use) and several clinical findings. The objective of this study was to investigate the association of sunbed use with established melanoma's risk factors such as high nevus count, presence of atypical nevi and lentigines as well as with suspected skin cancers detected by dermatologists during the Euromelanoma screening.
Materials and methods

Euromelanoma campaign and questionnaire
The Euromelanoma campaign was organized annually by the Euromelanoma Networking Group, under the auspices of the European Academy of Dermatology and Venereology (EADV) and the European Association of Dermato-Oncology (EADO). Every year, a media campaign focusing on particular aspects of skin cancer prevention was conducted on TV, radio, newspapers/magazines and Internet (www.euromelanoma.org) during the month of April. The campaign then culminated each year with the Euromelanoma day (usually in May), during which free-of-charge skin examinations were offered by both public and private dermatology clinics in several European countries. As previously described, 20, 21 participants were evaluated by means of the Euromelanoma questionnaire, which was standardized for all participating countries since 2009. The questionnaire was divided in two sections: the first was to be completed by the screenees and enquired about their demographics and risk factors; the second was then filled in by the screening dermatologist and focused on clinical findings that emerged during the visit. Questionnaires were sent to the coordinator centre of each country and data were then entered in a unique database (developed with Limesurvey version 1.82+), located at the Department of Dermatology, Universit e Libre de Bruxelles, Brussels, Belgium.
Statistical analysis
The variable 'any sunscreen use' (no/yes) was created by pooling together sunscreen use when outdoors for >1 h and sunscreen use when sunbathing. The variable 'any sun exposure' (no/yes) was created by pooling together outdoor occupation, history of sunburn and sunny holidays. Sunbed use was investigated by two questions: 'Do you use solarium?' (possible answers 'No', 'Yes, ≤20 sessions/year', 'Yes, >20 sessions/year') enquired about current sunbed use; and 'Number of years using solarium (including in the past only)' enquired about duration of ever sunbed use. Participants not reporting current sunbed use but reporting duration of sunbed use were considered ever users along with those reporting current use.
The following clinical variables were used as endpoints: presence of suspected melanoma, presence of suspected basal cell carcinoma (BCC), presence of suspected squamous cell carcinoma (SCC), presence of actinic keratoses (AKs), nevus count, presence of atypical nevi (defined as nevi with asymmetric, illdefined borders, irregular pigmentation and diameter >6 mm) and presence of lentigines on the back/chest, all categorized as no/yes variables.
Descriptive statistics, with frequencies, median values and interquartile ranges, are presented to report the socio-demographic characteristics of the surveyed population. Percentages and 95% confidence intervals (CIs) are presented to define the 
Data quality control: inclusion and exclusion criteria for countries' eligibility
Important clinical endpoints of this study were represented by suspected skin cancers; indeed, if a suspicious lesion was found during the screening, patients were advised for further diagnostics and treatment, but follow-up data on diagnosis were not collected in all countries due to privacy and legislative issues. Taking into consideration the lack of histopathological confirmation of suspected lesions, we performed a strict data quality check by which we formulated two inclusion criteria and two exclusion criteria for countries' participation in the multivariate analysis. Inclusion/exclusion criteria and related explanations are listed below. Inclusion criterion 1: <15% of missing values for suspected melanoma and/or suspected BCC and/or suspected SCC. Missingness can significantly distort the validity of the conclusions, by reducing the representativeness of the sample. 24 Inclusion criterion 2: <20% adolescents among participants. Adolescents are likely not to have had enough time to develop health consequences due to sunbed use, such as melanoma; indeed, a previous investigation showed an increased risk of melanoma associated with sunbed use ranging from 19% (non-significant) among adolescents to 49% and 61% (both significant) among 30-39 and 40-49 year olds. 25 Exclusion criterion 1: >10% of adolescents diagnosed with AKs. Estimates from these countries were judged unreliable, as AKs are extremely rare among adolescents. 26 Exclusion criterion 2: >20% of subjects with atypical nevi considered to have also a suspected melanoma. Probably, in these countries, atypical nevi were erroneously considered as suspected melanomas and therefore excised, although nevi and atypical nevi only rarely transform into melanomas. [27] [28] [29] [30] 
Results
Thirty countries took part in the Euromelanoma campaigns 2009-2014, for a total of 227 888 participants. Details of countries' participation over time are provided in Table S1 . Fourteen countries were not eligible for the multivariate statistical analysis, as they failed the data quality check. In particular, seven countries could not be considered as they did not satisfy inclusion criteria: Germany, Latvia, Russia, Spain, Turkey and Ukraine did not meet inclusion criterion 1 (they all had >15% of missing values for suspected melanoma and/or suspected BCC and/or suspected SCC; Table 1 ); Romania did not meet inclusion criterion 2 (30.2% of participants were adolescents; Table S2 ). Moreover, seven other countries had to be subsequently removed as they fulfilled exclusion criteria: Moldova met exclusion criterion 1, as Russia would have done too had it been included (12.5% and 13.1% of adolescents diagnosed with AKs, respectively; Table S3 ); Croatia, Cyprus, Denmark, Lithuania, Malta and Serbia met exclusion criterion 2 (>20% of subjects with atypical nevi considered to have also a suspected melanoma), as Germany would have done too had it been included (Table 2) .
Consequently, 16 countries were included in the main analysis, for a total of 145 980 participants. Details about the demographic, phenotypic and sunbed variables for each eligible country are presented in Table S4 . Overall, 64.8% were females and 35.2% males; median age was 43 years (interquartile range 31-59, 6.9% adolescents); 62.3% attained high education and 37.7% low education; 28.5% reported skin type I-II and 71.5% skin type III-VI. Ever use of sunbed was reported by 11.0% of those who responded to the sunbed questions (15 650/142 204).
Melanoma suspicion rate varied from 1.2% (Portugal) to 7.0% (Slovenia) and was higher than BCC suspicion rate in 6 of 16 (37.5%) countries and than SCC suspicion rate in 16 of 16 (100%) countries (Table 3) .
The summary estimate suggested a significant, independent association between suspected melanoma and ever sunbed exposure, with between-country heterogeneity [SOR = 1.13 (1.00-1.27), I2 = 11%] (Fig. 1a) .
The SOR of suspected NMSC (pooling together suspected BCC, suspected SCC and AKs) for ever sunbed use was 1.00 (0.91-1.10), without between-country heterogeneity (I 2 = 0%; Fig. 1b) . Models assessing the association of ever sunbed use with suspected NMSC combined in different ways (including suspected BCC and suspected SCC but excluding AKs or including suspected BCC alone, suspected SCC alone or AKs alone) produced similar results (data not shown). Furthermore, the summary estimates suggested significant, independent associations between ever sunbed use and: naevus count >50 [SOR = 1.05 (1.01-1.10), I 2 = 0%] (Fig. 2) ; presence of atypical nevi [SOR = 1.04 (1.00-1.09), I 2 = 0%] (Fig. 3) ; and lentigines, [SOR = 1.16 (1.05-1.29), I 2 = 68%] (Fig. 4) . Estimates for dose-response effect were not available due to low numbers of intermediate and high sunbed users (data not shown).
Discussion
The use of sunbeds is currently permitted in Europe, but restrictions related to age and skin type of users have been put in place in several European countries. The European legislation for sunbeds, which falls within the Low Voltage Directive (2014/35/EU) for electrical equipment, sets the limits for UV radiation emission to 300 mW/m 2 of total effective irradiance (harmonized European standard EN 60335-2-27:2013). Recently, though, artificial tanning has been declared unsafe by the European N (%) shown in each box. Countries in which>20% of subjects with atypical nevi were considered to have also a suspected melanoma are highlighted in bold.
Commission, whose Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) stated that there is no safe limit for exposure to UV radiation from sunbeds. 31 To corroborate the official opinion of the SCHEER, we decided to exploit the Euromelanoma database, which included information about a large number of participants from 30 countries. Our goal was to investigate the association of sunbed use with well-established risk factors, namely suspected skin cancer, nevus count, presence of atypical nevi and lentigines. Our multivariate analysis found a significant association between ever exposure to sunbeds and suspected melanoma, after adjustment for potential confounders. Although it was impossible in this study to ascertain whether suspected melanomas were confirmed as such by histopathology, this result appears to confirm the current evidence that sunbed use increases melanoma risk. In particular, our estimate was consistent with those found in previous meta-analyses assessing melanoma risk associated with ever using sunbeds: 15% by the IARC, by Hirst et al., 3 and 25% by Gallagher et al. 8 Like others before, 6, 32 Burgard and co-workers recently raised criticisms about the association between sunbed use and melanoma risk, including limitations of individual studies (selection and recall biases, typical of case-control studies; non-adjustment for certain confounders) and lack of large randomized or prospective studies (which in the case of sunbeds would be unethical or too costly, respectively). Yet, they found similar results in their meta-analysis, even using a different statistical method. 7 In spite of their scepticism then, we believe their recent meta-analysis actually adds to the body of evidence suggesting that sunbed use should be strongly discouraged in order to reduce melanoma risk.
Although the relationship between sunbed use and increased risk of NMSC has been established by previous meta-analyses, [2] [3] [4] [5] unfortunately, we were not able to confirm this association. Possible explanations include the lack of histopathological confirmation of the suspected NMSC and the relatively young age of the screenees (median 43 years), which could suggest that participants did not have sufficient time to develop NMSC -which usually occurs later in life than melanoma. 33 This is corroborated by the fact that in the present study, NMSC was suspected less than melanoma in multiple countries, in spite of NMSC being much more common than melanoma in epidemiological investigations. [34] [35] [36] [37] We found a significant association between ever sunbed use and lentigines after adjustment for potential confounders, including sun exposure and sunscreen use. This confirms previous case reports of lentigines occurring after sunbed exposure. [14] [15] [16] [17] [18] [19] Interestingly, these observations reported that the lentigines induced by artificial tanning (so-called 'sunbed lentigines') have more worrisome pathologic and ultra-structural features than common solar lentigines, such as the presence of melanocytic nuclear atypia and abnormally clumped, pleomorphic melanosomes. Moreover, excised 'sunbed lentigines' lacked solar elastosis, which is instead typical of common solar In order to calculate the odds ratio for Georgia, the model for this country was not adjusted for age, skin type and personal history of skin cancer, due to frequency of suspected melanoma being too low in exposed individuals. 2 A sensitivity analysis for Ireland, the only country with a considerable amount of missing data on sunbed use (20.3%, Table S2) found that the odds ratio of suspected melanoma associated with the missing values was similar to the odds ratio for exposed individuals [6.31 (0.74-53 .71) and 6.27 (0.69-57.27), respectively]. B. Non-melanoma skin cancer (NMSC). Heterogeneity I 2 = 0% for all countries. 1 The odds ratio for Georgia was not available, due to frequency of suspected NMSC being too low in exposed individuals The odds ratio for Ireland was not available, due to frequency of high nevus count being too low in exposed individuals. 
lentigines;
38 this suggests an acute phenomenon rather than a chronic one, consistent with excessive UV exposure resulting from indoor tanning. The potential of sunbed exposure to cause melanocytic atypia might explain the significant, though small association of ever sunbed use with atypical nevi in our multivariate analysis. In 1989, Roth et al. 16 described the case of a woman developing several dysplastic junctional nevi after an extended period of UVA tanning booth use. To our knowledge, the present study provides the first significant association between ever use of sunbeds and presence of atypical nevi in a large multivariate analysis. Evidently, this result is of utmost importance as atypical nevi represent a significant risk factor for melanoma development. 39 Exposure to solar UV radiation has been associated with high nevus count by a number of investigations. [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] The question arises as to whether exposure to UV radiation coming from sunbeds is also associated with high nevus count. Recently, Little and Lloyd observed that patients with a self-reported history of sunbed use displayed an increased frequency of multiple junctional nevi located on the buttocks, an area usually protected from sun exposure but not from tanning bed exposure. 13 Previously, Gellen et al. 11 reported in a large sample of Hungarian students that sunbed users were twice as likely to have >20 nevi as compared to non-users, after adjustment for skin colour, sunbathing and sunburn. Li et al. 12 found a significant, independent association between increasing number of annual sunbed sessions and higher nevus count in a large cohort of women. Our results corroborate these data by showing a significant association of sunbed ever use with high nevus count (>50 nevi), after controlling for any type of sun exposure and other confounders. Although this study was not designed to assess whether sunbed use increases the number of nevi and although we cannot exclude with absolute certainty that some solar lentigines were misdiagnosed as melanocytic nevi during the Euromelanoma screening, we believe this result is highly important because it suggests that sunbed use might possibly increase the number of nevi -and therefore the risk of melanoma 39,59,60 -independently from sun exposure. At any rate, individuals with high nevus count and/or atypical nevi should be particularly discouraged to use sunbeds because of a possible multiplicative effect of high nevus count, atypical nevi and indoor tanning on melanoma risk. Indeed, it was suggested that the negative impact of sunbed exposure on melanoma risk is generally greater in individuals with high-risk phenotypes. 25 The obvious limitation of this study was that two important clinical endpoints (melanoma and NMSC) were represented by suspected rather than histopathologically confirmed lesions. However, we performed a strict data quality control (that forced us to exclude data of 14 countries from the main analysis) to ensure the reliability of our data; the fact that we obtained a SOR for suspected melanoma similar to the risk estimates obtained for histopathologically proven melanomas by previous Figure 4 Forest plot of association of lentigines on back/chest with ever use of sunbeds. Heterogeneity I 2 = 68% for all countries. All odds ratios are adjusted for age, gender, education, skin type, family history of melanoma, personal history of skin cancer, any sun exposure and any sunscreen use. FYROM, Former Yugoslav Republic of Macedonia. meta-analyses supports the validity of our results. Another limitation is that the study was not population based but instead included participants self-attending a skin cancer screening event: therefore, a selection bias (either towards a more responsible or irresponsible population as for indoor tanning practices; or towards more aware participants as for the presence of suspected lesions) as well as a desirability bias [under-reporting of a 'bad habit' (sunbed use) to please doctors] cannot be excluded. As a consequence, one might expect a high prevalence of risk factors among the study participants, who may be more likely to attend if they have noticed a suspicious lesion on their body or if they have used a sunbed in the past and are worried about skin cancer risk. However, if over-reporting of sunbed use by subjects aware of the risk may have rendered the association with the clinical endpoints stronger, on the other hand, under-reporting of sunbed use could have influenced the results towards a weaker association, thus producing a counterbalance of the above-mentioned limitations. A further limitation is that the study was retrospective, therefore, a recall bias cannot be ruled out. 61 The strengths of the study were the extremely large sample size, the use of a standardized questionnaire in all participating countries, the strict control of the quality of the data and the thorough multivariate analysis that included many potential confounders.
In conclusion, we presented a large, comprehensive European investigation about multiple skin cancer risk factors connected to sunbed use among participants in the Euromelanoma campaign. This study indicates that indoor tanning is associated with important risk factors for melanoma such as high nevus count, presence of atypical nevi and lentigines, as well as suspicion of melanoma. In order to reduce the prevalence of melanoma risk factors, avoidance or discontinuation of sunbed exposure should always be encouraged, especially but not exclusively in individuals with high-risk phenotypes such as high nevus count and atypical nevi.
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